Watching Scribe Therapeutics Inc.? See every signal: funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planScribe Therapeutics Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Scribe Therapeutics Inc. filed amended and restated Certificate of Incorporation and Bylaws with Delaware on July 27, 2026, effective upon closing of its IPO. This routine corporate governance update reflects the company's transition to public company status and compliance with securities regulations.
Key Takeaways
Company completed its initial public offering on July 27, 2026, with final prospectus dated July 23, 2026
Amended and Restated Certificate of Incorporation and Bylaws were approved by board and stockholders and became effective at IPO closing
2 more takeaways
Filing Overview
What This Means
Scribe Therapeutics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.